📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Apthera

1.1 - Company Overview

Apthera Logo

Apthera

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of peptide-based cancer immunotherapy solutions for the treatment of breast and prostate cancers.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Apthera

Relief Therapeutics Logo

Relief Therapeutics

HQ: Switzerland Website
  • Description: Provider of clinical-stage biotechnological therapies based on molecules of natural origin (peptides and proteins), focusing on respiratory disease indications. Portfolio includes RLF-100 (Aviptadil) for acute and chronic lung diseases; Sentinox nasal spray; RLF-TD011 and Nexodyn AOS hypochlorous acid wound solutions; PKU GOLIKE for phenylketonuria; OLPRUVA for urea cycle disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Relief Therapeutics company profile →
Flexus BioSciences Logo

Flexus BioSciences

HQ: United States Website
  • Description: Provider of novel anti-cancer therapeutics created, developed, and commercialized through an innovative application of unexploited insights in immunology; privately-held biopharmaceutical company founded in 2013 and headquartered in San Carlos, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Flexus BioSciences company profile →
Trellis Bioscience Logo

Trellis Bioscience

HQ: United States Website
  • Description: Provider of therapeutic antibody therapies for infectious diseases and oncology, developing TRL1068 to disrupt bacterial biofilms and enhance antibiotics in prosthetic joint infections, TRL404 pan-influenza antibody cocktail, TRL3D3 targeting RSV, and TRL345 against cytomegalovirus, enabled by the CellSpot platform to discover high-affinity monoclonal antibodies from human memory B-cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trellis Bioscience company profile →
BlueSphere Bio Logo

BlueSphere Bio

HQ: United States Website
  • Description: Provider of TCXpress technology designed to unlock the potential of personalized T-cell therapy for the treatment of cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BlueSphere Bio company profile →
Allozyne Logo

Allozyne

HQ: United States Website
  • Description: Provider of technologies to improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics, including peptides, antibodies, and vaccines; developer of PEGylated IFN beta for treating multiple sclerosis. Founded in 2005, based in Seattle, Washington.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allozyne company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Apthera

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Apthera

2.2 - Growth funds investing in similar companies to Apthera

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Apthera

4.2 - Public trading comparable groups for Apthera

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Apthera

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Apthera

What does Apthera do?

Apthera is a provider of peptide-based cancer immunotherapy solutions for the treatment of breast and prostate cancers.

Who are Apthera's competitors?

Apthera's competitors and similar companies include Relief Therapeutics, Flexus BioSciences, Trellis Bioscience, BlueSphere Bio, and Allozyne.

Where is Apthera headquartered?

Apthera is headquartered in United States.

How many employees does Apthera have?

Apthera has 1,000 employees 🔒.

When was Apthera founded?

Apthera was founded in 2010 🔒.

What sector and industry vertical is Apthera in?

Apthera is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Apthera

Who are the top strategic acquirers in Apthera's sector and industry

Top strategic M&A buyers and acquirers in Apthera's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Apthera?

Top strategic M&A buyers groups and sectors for Apthera include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Apthera's sector and industry vertical

Which are the top PE firms investing in Apthera's sector and industry vertical?

Top PE firms investing in Apthera's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Apthera's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Apthera's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Apthera's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Apthera include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Apthera's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Apthera?

The key public trading comparables and valuation benchmarks for Apthera include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Apthera for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Apthera with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Apthera's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Apthera with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Apthera's' sector and industry vertical?

Access recent funding rounds and capital raises in Apthera's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Apthera